The meeting with be held at CPhI and focus on challenges specific to women in pharma.
Ian Wilcox, industry analyst and Vice President at the Hay Group, offered some stark statistics that highlight the issue of female leadership in pharma, citing that just 17% of the management teams among the top 20 pharmaceutical companies (ranked by sales), have senior female executives represent. The presence of women on the boards of these companies amounts to, “on average at 27% and as high as 45%—demonstrating that while the industry values the contributions of women, it has not yet been able to translate that recognition into talent acquisition and development programs that extend gender diversity to the executive ranks.”
However, the community of women in pharma is growing ever-more active. Leading the charge, CPhI introduced its Women in Leadership Forum three years ago and is looking to repeat last year’s successful event at CPhI North America in Philadelphia on May 18th. CPhI organizers find that as much as organizations have an obligation to ensure diversity and inclusion in the workplace, women can also identify opportunities and position themselves for senior leadership roles.
"We launched the Women in Leadership Forum at CPhI Worldwide in 2014 and we are excited to bring this success and passion to the North American pharmaceutical and specialty chemicals markets," remarked Robyn Duda, CPhI North America and InformEx Portfolio Director on announcing the 2017 event. Scheduled from 8:00–10:00 am, the Women in Leadership Forum will feature an executive panel of women from the pharmaceutical and specialty chemicals markets to discuss strategies and address the challenges women face climbing the corporate ladder.
Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.